Enbrace Hr Capsule, Delayed Release Pellets
Pricing Report NDC 64661-650-30

Current NADAC: $4.47914 per EA · Effective Sep 23, 2026 · Est. package price $134.37 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Enbrace Hr (NDC 64661-650-30) is $4.47914 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Jaymac Pharmaceuticals, Llc, this medication is distributed in a 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.47914
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 23, 2026
Billable Units
30 EA
Estimated Package Price
$134.37
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
64661-650-30
Description
30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2019, the NADAC wholesale price for (NDC ) has moved within a range of $4.21578 to $4.78284 per EA. Over this 6 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.2158 - $4.7828
Market Volatility
13.45% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $4.47914 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 19, 2026 $4.47818 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2026 $4.48394 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2026 $4.48695 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 20, 2026 $4.49277 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2026 $4.49077 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 18, 2026 $4.49787 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 18, 2026 $4.49599 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 21, 2026 $4.49149 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 17, 2025 $4.49484 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2025 $4.48780 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 22, 2025 $4.48520 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026